Dr. Agarwal’s Health Care Limited, established in 2010, is a prominent provider of comprehensive eye care services in India. The company offers a wide range of treatments, including cataract and refractive surgeries, consultations, diagnostics, non-surgical interventions, and the sale of optical products, contact lenses, accessories, and eye care-related pharmaceuticals.
As of September 30, 2024, Dr. Agarwal’s Health Care Limited operated a network of over 150 hospitals across India and Africa, staffed by 737 doctors. During this period, the company served 2.13 million patients and performed 220,523 surgeries, solidifying its position as a leader in the eye care sector.
In January 2025, the company launched its Initial Public Offering (IPO), opening on January 29 and closing on January 31. The IPO was priced between ₹382-402 per equity share, with a total issue size of approximately ₹3,027.76 crore, comprising both fresh issues and an offer for sale.
Dr. Agarwal’s Health Care Limited is recognized for its expertise in ophthalmology, offering advanced treatment options for various eye-related issues. The company’s commitment to innovation and excellence has established it as a trusted name in eye care services.
The company’s shares are listed on major stock exchanges, including the National Stock Exchange (NSE) under the symbol ‘AGARWALEYE’.
With a market share of approximately 25% in India’s organized eye care service chain segment as of FY 2024, Dr. Agarwal’s Health Care Limited continues to expand its reach and enhance patient outcomes, setting new benchmarks in the healthcare industry.
Dr. Agarwal’s Health Care Limited IPO Timetable
| Particular | Date |
| IPO Open Date | 29 Jan 2025 |
| IPO Close Date | 31 Jan 2025 |
| Allotment Date | 03 Feb 2025 |
| IPO Listing Date | 04 Feb 2025 |
Dr. Agarwal’s Health Care Limited IPO Details
| Issue Type | Book Built Issue IPO |
| Face Value | Rs. 1 Per Equity Share |
| IPO Price | Rs. 402 Per Equity Share |
| Market Lot | 35 Share |
| ISIN Code | |
| Listing At | NSE & BSE |
| Issue Size | Approx. Rs. 3027 Crore. |
Dr. Agarwal’s Health Care Limited IPO Lot Size
| Application | Lots | Shares | Amount |
| Minimum | 1 | 35 | Rs. 14070 |
| Maximum | 14 | 490 | Rs. 196980 |
| Small HNI (Minimum) | 15 | 525 | Rs. 211050 |
| Big HNI (Minimum) | 72 | 2520 | Rs. 1013040 |
Dr. Agarwal’s Health Care Limited IPO Allotment Status
Click Here To Check IPO Allotment Status Dr. Agarwal’s Health Care Limited IPO
Click Here To Get ASBA Forms Dr. Agarwal’s Health Care Limited IPO
Company Financials :
| Particular | 31 March 2024 | 31 March 2023 | 31 March 2022 |
| Total Assets | 2752.82 | 1825.17 | 1026.13 |
| Total Revenue | 1376.45 | 1031.49 | 713.78 |
| Profit After Tax | 95.05 | 103.23 | 43.16 |
Company Promoters:
The Promoters of the Company are Dr. Amar Agarwal, Dr. Athiya Agarwal, Dr Adil Agarwal, Dr. Anosh Agarwal, Dr Ashvin Agarwal, Dr. Ashar Agarwal, Dr. Amar Agarwal Family Trust, Dr Adil Agarwal Family Trust, Dr. Anosh Agarwal Family Trust, Dr Ashvin Agarwal Family Trust, Dr. Ashar Agarwal Family Trust, Dr Agarwal’s Eye Institute and Dr Agarwal’s Eye Institute Private Limited
Objects of this Issue:
- Repayment/prepayment, in part or full, of certain of the borrowings and
- General corporate purposes and unidentified inorganic acquisition.
Registrar & Company Details
| Company Contact Information | IPO Registrar |
| Dr. Agarwal’s Health Care Limited 1 st Floor, Buhari Towers No.4, Moores Road, Off Greams Road, Near Asan Memorial School, Chennai 600 006 Phone: +91 44 4378 7777 Email: secretarial@dragarwal.com Website: https://dragarwals.co.in/ | Kfin Technologies Limited Phone: 04067162222, 04079611000 Email: ahcl.ipo@kfintech.com Website: https://kosmic.kfintech.com/ipostatus/ |
